Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does prolonged clopidogrel therapy improve outcome in patients with drug-eluting or bare-metal stents?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 302–303 (2007)Cite this article

Access through your institution
Buy or subscribe

boxed-textEisenstein EL et al. (2007) Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 297: 159–168

Background

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mehta SR et al. for the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358: 527–533

    Article  CAS  Google Scholar 

  2. Steinhubl SR et al. for the Clopidogrel for the Reduction of Events During Observation (CREDO) Investigators (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288: 2411–2420

    Article  CAS  Google Scholar 

  3. Chieffo A (2006) Influence of prolonged dual anti-platelet use on late stent thrombosis in a large real-world registry: the Milan/Siegburg experience. Presented at Transcatheter Cardiovascular Therapeutics 18th Annual Scientific Symposium: 2006 October 22–27, Washington, DC

  4. Mauri L et al. (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356: 1020–1029

    Article  CAS  Google Scholar 

  5. Daemen J et al. (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369: 667–678

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. and Head of the Interventional Department, J Daemen is a Research Fellow in Interventional Cardiology and PW Serruys is Professor of Interventional Cardiology, Director of the Clinical Research Program at the Catheterization Laboratory, both at the Thoraxcenter, Erasmus University, Rotterdam, The Netherlands. PW Serruys is also an Advisory Board member of Nature Clinical Practice Cardiovascular Medicine.,

    Joost Daemen & Patrick W Serruys

Authors
  1. Joost Daemen
    View author publications

    Search author on:PubMed Google Scholar

  2. Patrick W Serruys
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Joost Daemen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daemen, J., Serruys, P. Does prolonged clopidogrel therapy improve outcome in patients with drug-eluting or bare-metal stents?. Nat Rev Cardiol 4, 302–303 (2007). https://doi.org/10.1038/ncpcardio0881

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncpcardio0881

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing